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Abstract
Human endometrium resists embryo implantation except during the ‘window of receptivity’. A change in
endometrial gene expression is required for the development of receptivity. Uterine calbindin-D28k (CaBP-28k) is
involved in the regulation of endometrial receptivity by intracellular Ca2+. Currently, this protein is known to be
mainly expressed in brain, kidneys, and pancreas, but potential role(s) of CaBP-28k in the human uterus during the
menstrual cycle remain to be clarified. Thus, in this study we demonstrated the expression of CaBP-28k in the
human endometrium in distinct menstrual phases. During the human menstrual cycle, uterine expression levels of
CaBP-28k mRNA and protein increased in the proliferative phase and fluctuated in these tissues, compared with
that observed in other phases. We assessed the effects of two sex-steroid hormones, 17beta-estradiol (E2) and
progesterone (P4), on the expression of CaBP-28k in Ishikawa cells. A significant increase in the expression of CaBP-
28k mRNA was observed at the concentrations of E2 (10(-9 to -7) M). In addition, spatial expression of CaBP-28k
protein was detected by immunohistochemistry. CaBP-28k was abundantly localized in the cytoplasm of the
luminal and glandular epithelial cells during the proliferative phases (early-, mid-, late-) and early-secretory phase of
menstrual cycle. Taken together, these results indicate that CaBP-28k, a uterine calcium binding protein, is
abundantly expressed in the human endometrium, suggesting that uterine expression of CaBP-28k may be
involved in reproductive function during the human menstrual cycle.
Background
Intracellular calcium binding proteins (calbindins) are
critical for regulating the availability of calcium ions
(Ca
2+) within cells. There are two types of cytosolic cal-
bindins, calbindin-D9k (CaBP-9k) and calbindin-D28k
(CaBP-28k), which are cytosolic proteins differentially
regulated by steroid hormones in the uterus [1,2]. In
addition to its traditional role in extracellular calcium
homeostasis [3], vitamin D influences a broad range of
cellular events, ranging from oncogene expression [4]
and immunoregulation [5] to cellular differentiation
[6,7] and intracellular calcium metabolism [8]. Previous
studies have documented that vitamin D deficiency
decreases fertility in female rats [9-11], and vitamin
D-dependent calcium-binding proteins were discovered
in reproductive tissues: CaBP-9k in the uterus of rats
[12-14], and the larger CaBP-28k in the uterus of
domestic fowl [15,16].
The expression of CaBP-9k and CaBP-28k in repro-
ductive tissues is affected by steroid hormones
[12,14,15,17]. For example, the expression of CaBP-9k
mRNA in the mouse uterus was significantly increased
by treatment with P4 and E2 plus P4, but not by E2
alone [18,19]. Conversely, rat uterine CaBP-D9k mRNA
was induced only by E2 [20]. In hens, uterine expression
of the larger calbindin-D28k increased by the addition of
testosterone [15].
Embryo implantation is a complex process involving
interactions between the blastocyst and the uterus.
A successful implantation requires the development of
the blastocyst stage, its escape from the zonapellucida,
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primate endometrium undergoes certain hormone-
dependent changes during a particular time window
within the preimplantation phase that prepares it to
receive the growing blastocyst [22-24]. A complex inter-
action between effectors, including steroid hormones,
growth factors, and cytokines, regulates development of
the “receptivity” state of the uterine epithelium [25-28].
The action of calcium ions in female reproductive
organs has also been widely studied for several decades.
It has been suggested that calcium ions are involved in
uterine smooth muscle contraction and fetal implanta-
tion [1,29,30]. Additionally, the balance of calcium ions
during uterine contraction and relaxation is extremely
important throughout pregnancy and during labor.
However, the mechanism of regulation of calcium levels
in uterine tissue remains largely unknown. In the pre-
sent model of calcium flux in uterine tissue, calcium
ions flow into the cytoplasm through ion transport pro-
teins, exchangers, or calcium-binding proteins, i.e.,
CaBP-9k and CaBP-28k. Furthermore, the mechanism
and regulation of calcium-related genes in the uterus
are not fully characterized, and it is likely that the regu-
lation of calcium ion flux is complex and involves a
diverse set of proteins. For instance, implantation in
CaBP-9k knockout mice appears to occur normally,
while CaBP-9k/CaBP-28k double knockout mice experi-
ence failed embryo implantation [28]. These results
demonstrate that the expression patterns of CaBP-28k
m a yb ei n v o l v e di nr e p r o d u c t i v ef u n c t i o na n df e t a l
implantation during the menstrual cycle in female mice.
In our previous studies, the expression of uterine
CaBP-28k mRNA and protein in mice during the estrus
cycle is regulated by sex-steroid hormones [18,31]. How-
ever, the role of CaBP-28k in the human uterus has yet
to be fully characterized. It is likely that CaBP-28k is
functionally important in female reproductive organs.
We examined the effect of steroid hormones E2 and P4
on the expression of CaBP-28k in the human endome-
trial tissues during the different stages of the menstrual
cycle and in Ishikawa endometrial cancer cells. In addi-
tion, we also examined the intracellular localization of
uterine CaBP-28k in human female endometrial tissue.
Methods
Materials
17b-Estradiol (E2), progesterone (P4), and mifepristone
(RU486) were obtained from Sigma-Aldrich Corporation
(St. Louis, MO). ICI 182 780 was purchased from
TOCRIS (Avonmouth, UK).
Endometrial tissue
Human endometrial tissues were collected by curettage
from women (the ages of 28-45 years) undergoing
hysteroscopy for investigation of tubal p"36atency or
tubal ligation. Endometrial tissues were classified
according to the most recent menstrual period, and his-
tology was performed according to the criteria of Noyes
et al. [32]. Approval was given by the Human Ethics
Committee at SCH Medical Center (Bucheon, Korea),
and signed consent was obtained in every case. Human
uterine finally classified samples (total n = 42) were
divided into seven groups (n = 6 in each period): men-
strual, proliferative (early, mid, late), and secretory phase
(early, mid, late). Endometrial tissues were transported
to the laboratory in buffered neutral formalin (10%) on
ice. Tissues were then quickly frozen in liquid nitrogen
and stored at -70°C until further use.
Cell culture and treatment
Ishikawa cells were obtained from Sigma-Aldrich (St.
Louis, MO). The cells were grown as monolayer cultures
in Dulbecco’s Modified Eagle Medium (DMEM; Gibco
BRL, Grand Island, NY), supplemented with 10% fetal
bovine serum (FBS; Gibco BRL), 100 IU/mL penicillin,
and 100 μg/mL streptomycin (Gibco BRL) at 37°C in a
humidified atmosphere of 95% O2 and 5% CO2.T o
challenge Ishikawa cells to E2 and P4, the cells were pla-
ted and grown to 70-80% confluence in six-well plastic
tissue culture dishes (NUNC™, Roskilde, Denmark). In
order to ensure depletion of steroid hormones and
growth factors in the cells, the growth medium was
replaced with starvation media containing phenol red-
free DMEM with 5% dextran-coated charcoal-stripped
FBS, 100 IU/mL penicillin, and 100 μg/mL streptomy-
cin, as described previously [33]. The Ishikawa cells
were maintained on starvation media for 3 days before
exposure to three concentrations of E2 (10
-9 M, 10
-8 M,
and 10
-7 M) and P4 (10
-7 M, 10
-6 M, and 10
-5 M). To
further investigate whether ER or PR is involved in the
expression of CaBP-28k protein, the cells were pre-
treated with ICI 182 780 (10
-6 M) or mifepristone (10
-6
M) for 60 min prior to the treatment with E2 (10
-8 M)
or P4 (10
-6 M). Each chemical was dissolved in DMSO
and added to the starvation media with the final DMSO
concentration being 0.1%. DMSO alone was used as a
negative control. Ishikawa cells were harvested 48 h
after treatment with E2 or P4 to measure mRNA levels,
and whole cells were harvested for mRNA and Western
blot analyses. All experiments were performed in tripli-
cate (group n = 3).
Total RNA extraction and quantitative real-time PCR
Endometrial tissues were transported, rapidly excised,
and washed in cold, sterile NaCl (0.9%). Total RNA was
prepared with Trizol reagent (Invitrogen, Carlsbad, CA),
and the concentration of RNA was determined by
absorbance at 260 nm. Total RNA (1 μg) was reverse
Yang et al. Reproductive Biology and Endocrinology 2011, 9:28
http://www.rbej.com/content/9/1/28
Page 2 of 8transcribed into first-strand cDNAs using Moloney mur-
ine leukemia virus (MMLV) reverse-transcriptase (Invi-
trogen, Carlsbad, CA) and random primers (9-mers;
Takara Bio Inc., Otsu, Shiga, Japan). Two microliters of
cDNA template was added to 10 μL of 2× SYBR Premix
Ex Taq (TaKaRa Bio) and 10 pmol of each specific pri-
mer. The reactions were carried out for 40 cycles
according to the following parameters: denaturation at
95°C for 30 s, annealing at 58°C for 30 s, and extension
at 72°C for 45 s. The oligonucleotide primers for CaBP-
28k were 5’- AGT GGT TAC CTG GAA GGA AAG G
-3’ (sense) and 5’- AGC AGG AAA TTC TCT TCT
GTG G -3’ (antisense). The primers for GAPDH were
5’- GGT GTG AAC CAT GAG AAG TAT GAC -3’
(sense) and 5’- AGT AGA GGC AGG GAT GAT GTT
CT -3’ (antisense). Fluorescence intensity was measured
a tt h ee n do ft h ee x t e n s i o np h a s eo fe a c hc y c l e .T h e
threshold value for the fluorescence intensity of all sam-
ples was set manually. The reaction cycle at which PCR
products exceeded this fluorescence intensity threshold
was identified as the threshold cycle [34] in the expo-
nential phase of the PCR amplification. The expression
of calbindin-D28k was quantified against that of
GAPDH. Relative quantification was based on the com-
parison of CT [cycle threshold] at a constant fluorescent
intensity. The amount of transcript is inversely related
to the magnitude of observed CT, and for every two-
fold dilution in the transcript, CT is expected to
increase by one. Relative expression was calculated
using the equation R =2
-[ ΔCT sample - ΔCT control] [26].
To determine a normalized arbitrary value for each
gene, every obtained value was normalized to that of
GAPDH.
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was extracted and cDNA synthesized as
described in the preceding paragraph. RT-PCR was per-
formed as described by [35]. Denaturation was per-
formed at 95°C for 30 s, annealing at 58°C for 30 s (for
CaBP-28k) or at 55°C for 30 s (for GAPDH), and exten-
sion at 72°C for 30 s. Cycling kinetics were performed
using 20, 25, and 30 cycles, to ensure linearity of PCR
product detection, and the final PCR condition was 30
cycles for CaBP-28k or 25 cycles for GAPDH. Eight
microliters of PCR products was loaded on 2% agarose
gel and stained with ethidium bromide following elec-
trophoresis. The intensity of the PCR bands was deter-
mined directly by scanning the agarose gel and was
analyzed using the molecular analysis program version
4.5.1 (Gel Doc 1000, Bio-Rad, Hercules, CA).
Western blot analysis
Endometrial tissues were transported, rapidly excised,
and washed in cold sterile 0.9% NaCl solution. Protein
was extracted with Pro-prep (iNtRON Bio Inc, Sungnam,
Kyungki-Do, Korea) according to the manufacturer’s
instructions. The cells were harvested, washed two times
with ice-cold PBS, and then resuspended in 20 mM Tris-
HCl buffer (pH 6.4) containing protease inhibitors (0.1
mM phenylmethylsulfonyl fluoride, 5 μg/mL pepstatin A,
and 1 μg/mL chymostatin). Whole cell lysate was pre-
pared using 20 strokes of a Dounce homogenizer,
followed by centrifugation at 13,000g for 20 min at 4°C.
Proteins (70 μg per lane) were separated on a 10% SDS-
polyacrylamide gel electrophoresis (PAGE) gel and trans-
ferred to a polyvinylidene fluoride transfer membrane
(Perkin Elmer Co., Wellesley, MA) in a TransBlot Cell
(TE-22, Hoefer Inc, San Francisco, CA) according to the
manufacturer’s protocol. The resulting blot was blocked
in TBS-T (Tris-Buffered Saline Tween-20) containing 5%
skim milk for 60 min and then incubated with primary
antibody: CaBP-28k (goat-polyclonal, 1:500, Santa Cruz,
CA, USA) or GAPDH (mouse-monoclonal, 1:2000, Assay
Design Inc, Ann Abor, MI). After being washed in buffer,
the membranes were incubated with the appropriate
horseradish peroxidase-conjugated secondary antibodies
(anti-goat, 1:2000 or anti-mouse, 1:5000, Santa Cruz, CA)
for 1 h at room temperature (RT). After being washed,
the blots were developed by incubation in ECL chemilu-
minescence reagent (Santa Cruz, CA) and subsequently
exposed to Biomax™ Light film (Kodak) for 1-5 min.
Signal specificity was confirmed by blotting in the
absence of primary antibody, and bands were normalized
to GAPDH-immunoreactive bands visualized in the same
membrane after stripping. Density measurements for
each band were performed with NIH ImageJ software.
Background samples from an area near each lane
were subtracted from each band to obtain mean band
density.
Immunohistochemical staining
Localization of CaBP-28k protein was examined by
immunohistochemistry. Endometrial tissues were
embedded in paraffin, before sections (5 μm) were
deparaffinized in xylene and hydrated in descending
grades of ethanol. Endogenous peroxidase activity was
blocked with 3% hydrogen peroxide in TBS-T for
30 min. Nonspecific reactions were blocked by incubat-
ing the sections in 10% normal goat serum for 2 h at
RT. The sections were subsequently incubated at RT for
4 h with a polyclonal goat antibody directed against
CaBP-28k (diluted 1:300; Santa Cruz, CA, USA) dis-
solved in 10% normal goat serum. After being washed
with TBS-T, the sections were incubated with a biotiny-
lated secondary antibody (goat IgG, Vector Laboratories,
Burlingame, CA) for 30 min at 37°C and then incubated
with ABC-Elite for 30 min at 37°C. Diaminobenzidine
(DAB; Sigma) was used as a chromogen, and the
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by mounting in Canada balsam.
Data analysis
Data were presented as the means ± SEM and analyzed
by one-way analysis of variance (ANOVA), followed by
Tukey’s multiple comparison test. Statistical analysis was
performed using Prism Graph Pad (v4.0; GraphPad Soft-
ware Inc., San Diego, CA, USA). P <0 . 0 5w a sc o n s i d -
ered to be statistically significant.
Results
Pattern of endometrial calbindin-D28k expression
To investigate the expression of endometrial CaBP-28k dur-
ing the menstrual cycle, we divided the endometrial tissues
into seven groups [menstrual phase, proliferative phase
(early, mid, late), and secretory phase (early, mid, late)
according to the most recent menstrual period, and histol-
ogy according to the criteria of Noyes et al. [32]. In normali-
zation to GAPDH, CaBP-28k mRNA levels in the
proliferative phase (early, mid, late) and secretory phase
(early) were induced up to 1.5-, 2.5-, 2.5-, and 2.0-fold higher
than in the menstrual phase, respectively (Figure 1). This
induced expression of CaBP-28k was significantly decreased
in secretory phases (early, mid, and late) compared to that
in proliferative phases (mid and late phases). In parallel with
mRNA levels, the protein levels of CaBP-28k were higher in
the proliferative phase (early-, mid-, late-) than in the other
phases (Figure 2). This induced protein level of CaBP-9k
was also reduced in secretory phases compared to that of
proliferative phases as shown in Figure 2.
Effect of sex-steroid hormone E2 and P4 on regulation of
calbindin-D28k expression in Ishikawa cells
We assessed the effects of sex-steroid hormones E2 and
P4 on the regulation of CaBP-28k in Ishikawa cells.
A panel of chemicals comprising E2 and P4 were
applied to Ishikawa cells at increasing concentrations
(E2: 10
-9 Mt o1 0
-7 M, and P4: 10
-7 Mt o1 0
-5M). As
shown in Figure 3, a significant increase in the expres-
sion of CaBP-28k mRNA was observed in the cells trea-
ted with E2 (10
-9 Mt o1 0
-7M). Compared to vehicle
(negative) controls, CaBP-28k mRNA levels were
increased up to 2.0- and 2.5-fold, respectively (Figure 3).
Also, we elucidated the involvement of the estrogen
receptor (ER) in the E2-induced CaBP-28k increase in
Ishikawa cells by treating the cells with an ER antagonist
or PR antagonist (ICI and mifepristone, respectively) for
60 min prior to the treatment with E2 (10
-8 M) or P4
(10
-6 M). Pretreatment with an ER antagonist comple-
tely reversed the E2-induced increase in CaBP-28k
expression (Figure 4), suggesting that ERs are involved
in the E2-mediated regulation of CaBP-28k expression
in Ishikawa cells. Furthermore, after pretreatment with a
PR antagonist, the P4-induced CaBP-28k expression was
not changed, indicating that PRs are not involved in the
expression of CaBP-28k protein in Ishikawa cells.
Figure 1 Pattern of endometrial CaBP-28k mRNA expression.
Endometrial tissues were divided into 7 groups (M: menstrual
phase, EP: early-proliferative phase, MP: mid-proliferative phase, LP:
late-proliferative phase, ES: early-secretory phase, MS: mid-secretory
phase, LS: late-secretory phase) based on the endometrial tissues
classified according to the last menstrual period and histology
according to the criteria of Noyes et al [32]. Uterine calbindin-D28k
mRNA expression during the menstrual cycle was examined by (A:
RT-PCR; B: real-time PCR). A significant increase in calbindin-D28k
expression level was observed during menstrual cycle (
aP < 0.05 vs.
M,
bP < 0.05 vs. MP or LP).
Figure 2 Pattern of endometrial CaBP-28k protein expression.
Endometrial tissues were divided into 7 groups (M: menstrual
phase, EP: early-proliferative phase, MP: mid-proliferative phase, LP:
late-proliferative phase, ES: early-secretory phase, MS: mid-secretory
phase, LS: late-secretory phase) based on the endometrial tissues
classified according to the last menstrual period and histology
according to the criteria of Noyes et al [32]. Uterine CaBP-28k
protein expression during the menstrual cycle was examined by
WESTERN BLOT. A significant increase in calbindin-D28k expression
level was observed during menstrual cycle (
aP < 0.05 vs. M,
bP<
0.05 vs. MP or LP).
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endometrial tissue
To assess the spatial pattern of expression of CaBP-28k
in the endometrial tissue, we analyzed tissue sections at
different stages of the menstrual phases (early-, mid-,
late-proliferative phase or secretory phase) by immuno-
histochemistry using an anti-CaBP-28k antibody.
Endometrial CaBP-28k was highly expressed in cyto-
plasm of endometrial epithelial cells in early-, mid-, late-
proliferative phase compared to secretory phases. Addi-
tionally, in the early-secretory phase, CaBP-28k was
weakly expressed in the endometrial epithelial cells as
compared to the glandular epithelial cells (Figure 5).
Discussion
We have previously determined that calcium-related
proteins are regulated by sex-steroid hormones in the
uterus of rodents [26,31,36,37]. It is well known that the
status of the uterine cavity is important for successful
implantation and is influenced by the secretory activity
of the glandular epithelium [15,38,39]. In this study,
CaBP-28k mRNA and protein were expressed in human
endometrial tissues. The levels of calcium-related pro-
teins fluctuated in E2-predominant stages [20,26,37].
C a B P - 2 8 km R N Aa n dp r o t e i nw e r ee x p r e s s e da tt h e s e
stages [proliferative (early, mid, late) and secretory (only
early) phase], followed by a decline in the secretory
phase (mid-, late-) of the human endometrium, as
demonstrated in this study. This result is in agreement
with the pattern of CaBP-28k expression in the uterus
of both mice and humans [28]. Therefore, these results
indicate that this parallel pattern of CaBP-28k expres-
sion may be also involved in fetal implantation in
humans.
Moreover, the level of CaBP-28k mRNA was increased
by E2 (E2,1 0
-9 Mt o1 0
-7 M) in human endometrial
cancer cells (Ishikawa cells) as shown in this study. Sex-
steroid hormones can induce changes in the structure
and function of the uterus and regulate menstrual cycle
progression. To examine the effect of these hormones
on uterine CaBP-28k expression, we treated Ishikawa
cells with E2 (10
-8 M) or P4 (10
-6 M). Treatment with
E2 resulted in increased uterine expression of CaBP-28k
mRNA and protein, while P4 did not alter CaBP-28k
expression. The expression of several calcium-related
proteins is altered in an E2-dependent [31,37] or P4-
dependent [26,36] manner in the estrus cycle. It is parti-
cularly interesting that calcium-related proteins are
expressed during the estrus cycle, due to the wide varia-
tion in regulation of calcium-related protein expression
in the uterus across species. Calcium-related proteins,
which are crucial for early implantation, are also
expressed in the endometrial layer [27,28,39]. However,
it is still unclear why the uterine luminal epithelium
increases Ca
2+ uptake during implantation. In what
aspect would this uptake facilitate blastocyst attachment
at implantation? It is known that, for proper blastocyst
implantation in human and mice, there must be interac-
tion between adhesion-competent trophoblast cells and
endometrial extracellular matrix components. The accu-
mulation of integrin receptors for fibronectin on the
Figure 3 Effect of sex-steroid hormone E2 and P4 on
regulation of CaBP-28k mRNA expression. The cells were treated
with only DMSO (Ve, negative control), E2 (10
-9 to -7 mol), P4(10
-7 to
-5 mol) for 2 days. Graphs represent the analysis of real-time PCR
data.
aP < 0.05 indicate a significant difference in CaBP-28k
expression level compared to a negative control.
Figure 4 Effect of sex-steroid hormones and ER and PR
antagonists on regulation of CaBP-28k protein expression. The
cells were treated with only DMSO (Ve, negative control), E2 (10
-8M),
P4 (10
-6M) and/or ICI (ICI 182,780: 10
-6M), RU (RU486: 10
-6M) for
2 days and harvested 24 h following the final injection. Graphs
represent the analysis of Western blot data.
aP < 0.05 indicate a
significant difference in CaBP-28k expression level compared to a
negative control.
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extracellular matrix (ECM) [40], but only when the blas-
tocyst has reached an adhesion-competent state.
Recently, it has been shown that the development of an
adhesion-competent embryo is facilitated by heparin-
binding epidermal growth factor (EGF)-like growth fac-
tor (HB-EGF) and that this process is dependent on cal-
cium influx from extracellular sources [41]. The uterine
epithelium is a barrier to interstitial blastocyst implanta-
tion, and it is also an important participant in the
maternal-embryonic dialogue. During the periimplanta-
tion period, uterine epithelial cells produce HB-EGF
[42] and the uterine glands secrete calcitonin [43], two
paracrine or juxtacrine agents that are each capable of
accelerating blastocyst differentiation. It is intriguing
that the biological activity of both factors is dependent
on Ca
2+ signaling [44], which appears to regulate preim-
plantation embryogenesis beginning as early as the
maturing oocyte [45,46]. These data suggest that a pos-
sible source of this external calcium needed for HB-
EGF-mediated differentiation of the blastocyst to an
adhesion-competent state is from stores in the luminal
epithelium of the endometrium.
As previously shown, the initial up-regulation of
CaBP-28k increases the storage capacity for Ca
2+ in
luminal epithelial cells, and the subsequent specific
down-regulation leads to an increase in free Ca
2+ con-
centration [28]. In mammalian enterocytes, free Ca
2+
ions are bound to cytosolic CaBP-9k and transferred
across the cells by facilitatedd i f f u s i o n[ 4 7 ] .T h i st r a n s -
port of Ca
2+ by CaBP-9k helps to maintain homeostasis
by keeping intracellular Ca
2+ ion concentrations below
10
-7 M, preventing premature cell death by apoptosis.
Thus, it can be speculated that the role of CaBP-28k
protein in the uterine luminal epithelium is also to
enhance Ca
2+ uptake by increasing the cell-buffering
capacity and stimulating the calcium entry mechanism
in these cells. This release may trigger apoptosis in
these specific epithelial cells because high concentra-
tions of free Ca
2+ are reported to cause apoptosis in
many different cell types [48] and CaBP-28k is able to
inhibit apoptosis in osteoblastic cells [49]. This apopto-
sis could, in turn, destabilize the epithelial barrier at the
implantation site and facilitate trophoblast invasion and
implantation.
An immunohistochemistry study revealed that the
CaBP-28k protein was highly expressed in the cytoplasm
of endometrial epithelial cells in the early-, mid-, late-
proliferative compared with other phases, however, it
was weakly expressed in endometrial epithelial cells as
Figure 5 Localization of CaBP-28k protein in the human endometrium. Immunohistochemistry was performed to detect CaBP-28k protein
in different phases in the uterine sections during the menstrual cycle (a, early-proliferative phase; b, mid-proliferative phase; c, late-proliferative
phase; d, early-secretory phase; e, mid-secretory phase; f, late-secretory phase) as described in Materials and Methods. Arrowheads ®
endometrial epithelial cells, arrows ® endometrial glandular cells. Arrows and arrowheads indicate CaBP-28k-positive regions.
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early-secretory phase. In the previous study, it was parti-
cularly interesting to observe that the regions where the
uterine epithelium surrounded the implanting embryo
were negative for CaBP-9k mRNA, whereas uniform
expression was detected in the entire luminal epithelium
in the regions where no embryo was attached [19].
Although CaBP-9k expression is not detected in human
endometrium, either of CaBP-9k or CaBP-28k expres-
sion appears to be sufficient to facilitate implantation in
mice [27]. We did not examine expression pattern(s) of
CaBP-28k in the human uterus during pregnancy, partly
because it is difficult to collect uterine samples from
pregnant subjects due to ethical issues. Although we
established that CaBP-28k expression occurred only dur-
ing the menstrual cycle, we hypothesized that uterine
CaBP-28k may be effectively mediated through mater-
nal-fetal dialogue despite species differences between
human and rodents. Thus, we assumed that CaBP-28k
expression may be involved in endometrial receptivity
during the menstrual cycle in humans.
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